Mohammad Hirmand

Interim Chief Medical Officer, Medivation.

Companies

Whitehawk Therapeutics, Inc.Board member Mar 29, 2023 to now¹
Turning Point Therapeutics, Inc.EVP and Chief Medical Officer Dec 3, 2019 to Aug 17, 2022²
MedivationInterim Chief Medical Officer Oct 1, 2015 to Sep 30, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Turning Point Therapeutics, Inc.0 shares⁴Aug 17, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 17, 2022Returned to company 41,284 shares at $76.00 of Turning Point Therapeutics, Inc.⁴
Feb 9, 2022Granted 15,000 shares of Turning Point Therapeutics, Inc.⁵
Feb 9, 2022Granted 18,983 shares of Turning Point Therapeutics, Inc.⁵
Feb 9, 2022Sold 669 shares at $36.30 of Turning Point Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARWhitehawk Therapeutics, Inc., Board member
2
SEC EDGARTurning Point Therapeutics, Inc., EVP and Chief Medical Officer
3
SEC EDGARMedivation, Interim Chief Medical Officer
4
SEC EDGARTurning Point Therapeutics, Inc. shares after the filing of Aug 17, 2022
5
SEC EDGARForm 4 filed Feb 11, 2022